Potency assessment of topical corticoids in the vasoconstrictor assay and on tuberculin-induced inflammation.

Skin Pharmacol

Cutaneous Studies International (CSI), Freiburg, FRG.

Published: February 1992

The topical anti-inflammatory activity of potent and very potent corticoids was studied in normal and inflamed skin using the vasoconstriction assay and tuberculin-induced inflammation in four double-blind intraindividual comparison trials. Instrumental techniques in addition to visual scores and several time points were applied to get better insight into the reliability of the models and the sensitivity of the different variables. Beta-methasone-17-valerate and two concentrations of prednicarbate were used as potent corticoids, clobetasol-17-propionate, betamethasone-17,21-dipropionate and different biopharmaceutical forms of desoximetasone (DOM) as very potent corticoids. Visual scores, the reactive skin hyperemia after arterial occlusion and skin colorimetry were used to quantify vasoconstriction; erythema scores, surface area of infiltration and changes in skin colorimetry, skin blood flow and skin temperature for the tuberculin reaction. The time courses of blanching (n = 20) and of the tuberculin reaction (n = 10) were described by orthogonal polynomials and the coefficients were statistically analyzed by nonparametric tests, the discriminative variables in tuberculin inflammation in addition by the parametric multiple analysis of variance. Important differences in the release rates of corticoids demand several assessment times and not just one as often used. The potency ranking may otherwise be misleading. In general, ointments released corticoids slowlier than the cream which in turn liberated slowlier than the gels. The DOM gel declined rapidly after an apparent peak at 5.5 h in terms of its blanching effect, but was nevertheless comparable after once-daily application to other very potent corticoids in its activity against delayed-type inflammation. Such differences may explain discrepancies found for some corticoid preparations between their blanching response and clinical efficacy. The more potent a corticoid the more the erythema is reduced, the less pronounced the cell infiltration and the more delayed the peak seems from 24 to 48 h in the tuberculin reaction. The inflammatory response is diminished in the following manner: very potent greater than potent corticoids; erythema greater than infiltration. Visual scores were the most reliable parameters in normal and inflamed skin and they correlated well with skin colorimetry which shows greater variability. Reactive hyperemia after arterial occlusion gave poor results in terms of ranking in the vasoconstriction assay as did resting skin blood flow in inflamed skin. Changes in the temperature of inflamed skin are sensitive enough to discriminate the active drugs from the controls, but have a somewhat different time course, reflecting perhaps a higher impact of the amount of mediator release in the early phase relative to the cell invasion in the later phase.

Download full-text PDF

Source
http://dx.doi.org/10.1159/000210949DOI Listing

Publication Analysis

Top Keywords

potent corticoids
20
inflamed skin
16
visual scores
12
skin colorimetry
12
tuberculin reaction
12
skin
11
corticoids
8
assay tuberculin-induced
8
tuberculin-induced inflammation
8
potent
8

Similar Publications

Rheumatoid arthritis (RA) and myasthenia gravis (MG) are two distinct autoimmune diseases. Compared with the general population, the incidence of RA is notably higher among patients with MG. Similarly, the rate of MG in patients diagnosed with RA is also significantly increased.

View Article and Find Full Text PDF
Article Synopsis
  • Steatotic liver disease linked to metabolic dysfunction (MASLD) is prevalent in up to 30% of adults and is often associated with obesity and metabolic syndrome.
  • The study involved 42 patients split into three groups receiving different treatments: dietary advice only (CG), dietary advice plus aerobic exercise (AE + DA), and dietary advice plus high-intensity interval training (HIIT + DA).
  • Results showed that both exercise groups had significant reductions in cortisol levels, with HIIT + DA showing the greatest effects, and a notable decrease in hepatic steatosis was also observed, particularly in the AE + DA group.
View Article and Find Full Text PDF

Neuroprotective Effects of Dexamethasone in a Neuromelanin-Driven Parkinson's Disease Model.

J Neuroimmune Pharmacol

December 2024

Gene Therapy for CNS Disorders Program, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.

Parkinson's disease (PD) is characterized by the progressive loss of dopaminergic neurons in the substantia nigra that primarily affects movement control. Neuroinflammation plays a pivotal role in driving the disease's progression. The persistent inflammatory state in the brain exacerbates neuronal damage, creating a cycle that perpetuates the neurodegenerative process.

View Article and Find Full Text PDF
Article Synopsis
  • * After exposing rats to CuO for three weeks, researchers administered DHEA and quercetin for another three weeks, monitoring liver enzyme levels, antioxidant statuses, and signs of cell damage and death.
  • * Results showed that CuO exposure led to significant liver toxicity, but treatment with DHEA and quercetin reduced this damage, with their combined effect being particularly effective in improving liver health.
View Article and Find Full Text PDF

Oxytocin Protects Against Corticosterone-Induced DA Dysfunction: An Involvement of the PKA/CREB Pathway.

Neurochem Res

November 2024

Research Center for Neuroscience, Institute of Molecular Biosciences, Mahidol University, Nakhon Pathom, 73170, Thailand.

Article Synopsis
  • - Chronic stress negatively affects dopamine transmission, leading to mood disorders and conditions like ADHD, autism, schizophrenia, anxiety, depression, and drug addiction, while oxytocin plays a role in social behaviors and can counteract stress effects.
  • - This study examined how oxytocin can protect against dopamine dysfunction caused by corticosterone in neuroblastoma cells, revealing that corticosterone reduces key signaling molecules related to dopamine function, but oxytocin can mitigate this dysfunction.
  • - The protective effect of oxytocin operates through activation of protein kinase A (PKA) and involves oxytocin receptors, providing insights into stress resilience and possible treatments for disorders linked to dopamine issues.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!